ophthalmology

Darts failing to hit bullseye

Biotech

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Aviceda was also testing the nanoparticle in diabetic macular edema, but halted the study early due to insufficient supply and funding constraints.

Darren Incorvaia Dec 15, 2025 2:14pm

Close-up of human eye

Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug

Dec 3, 2025 8:25am

eyeball

Precise Bio completes 1st 3D-printed human cornea transplant

Nov 19, 2025 8:30am

Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Lilly bags eye-catching gene therapy in $475M deal

Nov 10, 2025 7:00am

Closeup of blue eye on black background

Italian biotech raises $141M series B to fund eye gene therapies

Nov 3, 2025 3:00am

Close-up of human eye

Science's retinal implant restores some vision in AMD patients

Oct 21, 2025 6:50am